Skip to main content

Birchview Capital, LP

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1618205 BURLINGTON, VT

Position in ACAD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,326,300
+$519,840 QoQ
Shares Held
171,000
0.0% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
2.04%
of 13F equity value
Holder Rank
#80
of 352 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Birchview Capital, LP holds $91,246,272 across 49 Biotechnology names. ACAD ranks #7 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 ACAD
Acadia Pharmaceuticals Inc
This page
171,000 $4,326,300

All Filings in ACAD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,326,300 171,000
2026-03-31 $3,806,460 171,000
2025-12-31 $4,567,410 171,000
2025-09-30 $3,649,140 171,000
2025-06-30 $4,050,846 187,800
2025-03-31 $4,375,074 263,400
2024-12-31 $6,209,640 338,400
2024-09-30 $6,158,152 400,400
2024-06-30 $4,069,000 250,400
2024-03-31 $4,629,896 250,400
2023-12-31 $7,526,924 240,400
2023-09-30 $5,009,936 240,400
2023-06-30 $5,973,130 249,400
2023-03-31 $4,693,708 249,400
2022-12-31 $3,970,448 249,400
2022-09-30 $4,080,184 249,400
2022-06-30 $3,514,046 249,400
2022-03-31 $4,829,468 199,400
2021-12-31 $4,653,996 199,400
2021-09-30 $3,312,034 199,400
2021-06-30 $4,863,366 199,400
2021-03-31 $4,566,600 177,000
2020-12-31 $5,452,920 102,000
2020-09-30 $4,207,500 102,000
2020-06-30 $4,507,710 93,000
2020-03-31 $3,887,000 92,000